Modulation of Signal Transducers and Activators of Transcription 1 and 3 Signaling in Melanoma by High-Dose IFNα2b
Wenjun Wang(UPMC Hillman Cancer Center), John M. Kirkwood(UPMC Hillman Cancer Center)
Cited by 110
Related Papers
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
|The Oncologist|2011|579
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced <i>BRAF</i>-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134
|Journal of Clinical Oncology|2022|427
Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab
|PLoS ONE|2014|309
Baicalein inhibits osteosarcoma cell proliferation and invasion through the miR‑183/Ezrin pathway
|Molecular Medicine Reports|2018|29